ArticleThe Indian journal of medical research2025
Decoding carbapenem resistant organisms (CROs) causing lower respiratory tract infections & their antimicrobial susceptibility pattern.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Lower Respiratory Tract Infections (LRTIs) pose a significant global health problem. Emergence of Carbapenem Resistant Organism (CRO) has complicated the treatment of these infections. We conducted a retrospective analysis to identify the prevalence of CROs causing LRTI and their antimicrobial susceptibility patterns. Methods A total of 1041 respiratory samples received in the department of Microbiology, Armed Forces Medical College, Pune were immediately processed as per standard guidelines and antimicrobial susceptibility was carried out with Vitek 2 Compact, Biomerieux. Results Klebsiella pneumoniae sub spp pneumoniae was the most isolated CRO in our study. A high level of resistance was observed among commonly used antibiotics in LRTIs. Interpretation & conclusions The resistance pattern highlights the limited efficacy of many standard antibiotics against CROs. This emphasizes the urgent need for antimicrobial stewardship and importance of colistin as the primary therapeutic choice, albeit with the need for prudent application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.